Quantbot Technologies’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.6K Buy
+2,324
New +$62.4K ﹤0.01% 1521
2024
Q2
Sell
-214,677
Closed -$3.32M 1632
2024
Q1
$3.32M Buy
214,677
+208,621
+3,445% +$2.35M 0.19% 140
2023
Q4
$53.9K Buy
+6,056
New +$44.8K ﹤0.01% 1319
2023
Q3
Sell
-121,647
Closed -$1.14M 1719
2023
Q2
$1.14M Sell
121,647
-118,175
-49% -$1.17M 0.07% 405
2023
Q1
$2.38M Buy
239,822
+113,356
+90% +$993K 0.17% 183
2022
Q4
$811K Buy
126,466
+53,943
+74% +$307K 0.06% 431
2022
Q3
$404K Sell
72,523
-2,564
-3% -$15.4K 0.03% 647
2022
Q2
$340K Sell
75,087
-23,360
-24% -$99.6K 0.03% 730
2022
Q1
$524K Buy
+98,447
New +$487K 0.05% 554
2021
Q2
Sell
-9,322
Closed -$123K 1613
2021
Q1
$123K Buy
+9,322
New +$156K 0.01% 836

Other funds holding HIMS

Quantbot Technologies's HIMS Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Hims & Hers Health (HIMS) in Q2 2026: 2,324 shares worth $80.6K. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in HIMS as recently as Q1 2024.

Quantbot Technologies first reported a position in HIMS in Q1 2021 and has held it in 10 quarters since. The position peaked at $3.32M in Q1 2024. 507 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Quantbot Technologies held 2,324 shares of Hims & Hers Health worth $80.6K as of Q2 2026.
  • Hims & Hers Health was a new Quantbot Technologies position in Q2 2026.
  • Hims & Hers Health made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1521 holding.
  • Quantbot Technologies first reported a position in Hims & Hers Health in Q1 2021 and has held it in 10 quarters since.
  • Quantbot Technologies's Hims & Hers Health position peaked at $3.32M in Q1 2024.
  • 507 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.